WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'1601 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 11'0851 Child (under 5 years) mortality rate: 212

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 82'056  80'722  79'392  78'076  76'775  66'137  56'337  44'932 
Births 1'901  1'898  1'892  1'881  1'865  1'640  1'742  1'697 
Surviving infants 1'866  1'862  1'854  1'842  1'824  1'588  1'626  1'493 
Pop. less than 5 years 9'268  9'237  9'131  8'923  8'755  7'808  8'266  6'894 
Pop. less than 15 years 25'555  25'275  24'964  24'605  24'311  23'430  22'265  18'105 
Female 15-49 years 21'023  20'693  20'373  20'071  19'743  16'032  12'872  10'219 

Number of reported case

(Click for retrospective incidence data for Egypt)
Diphtheria 59  333 
Japanese encephalitis
Measles 405  245  26  16  608  2'633  887  839 
Mumps 20'390  531  26  33  1'390 
Pertussis 49 
Polio* 565  2'006 
Rubella 34  35  30  461  608  24 
Rubella (CRS)
Tetanus (neonatal) 20  20  11  321  3'275  2'965 
Tetanus (total) 264  11  597  4'952  6'644 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Egypt)
Vaccine year result method % card seen                                                
BCG 2007  99  DHS   69  98  95  98  98  98  98  89  72 
DTP1 2007  100  DHS   69  97  94  97  97  97  98 
DTP3 2007  98  DHS   69  97  93  97  97  97  98  87  84 
HepB_BD         
HepB3 2007  96  DHS   69  97  93  97  97  97  98 
Hib3         
JapEnc         
MCV 2007  98  DHS   69  96  93  96  96  95  98  87  78 
MCV2          96  92  97  97  96  97 
PCV1         
PCV3         
Pol3 2007  95  DHS   69  97  93  97  97  97  98  87  84 
Rota1         
Rota_last         
Rubella1          96  96 
TT2plus 2002  35  DHS   74  71  61 
PAB         
VAD1          98 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Egypt)
BCG 98  95  98  98  98  98  89  50 
DTP1 97  94  97  97  97  98  95  80 
DTP3 97  93  96  97  97  98  87  57 
HepB3 97  93  96  97  97  98 
HepB_BD
Hib3
MCV 96  93  96  96  95  98  86  41 
MCV2 96  92  97  97  96  97 
PAB 86  86  86  86  85  80  74 
PnC3
Pol3 97  93  96  97  97  98  87  67 
Rota_last

Number of districts in the country 279  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 92
From 80 to 89% 2
From 50 to 79% 3
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 week; Yes
DT 2, 4, 6, 18 months; Yes risk groups
DTwP 18 months; Yes
DTwPHep 2, 4, 6 months; Yes
HepB 2, 4, 6 months; Yes Health workers and patients with renal dialysis
IPV Yes Immunocompromised children
MMR 12, 18 months; Yes
MenAC 3, 6, 12, 15 years; Yes
OPV birth; +1 week; 2, 4, 6, 9,12, 18 months; Yes
TT 1st contact; +2, +6 months; +1, +1 year; Yes CBAW
Td 7, 9 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2014    2010-2014  2007-2011    10 years  2'012 
Nº of districts with microplans that include activities to raise immunization coverage number 279  27  273  273  29  265  259 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 279  275  273  273  271  265  259 
Nº districts with DTP3 coverage >=80% number 262  259  264  267 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  94  97  98 
Nº districts with measles (MCV1) coverage >=95% number 218  242  241  244  233     
% of districts with MCV1 coverage >=95% From 0 to 100% 78  88  88  89  86     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  133  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.